A combination of two plasma-based biomarkers, tau phosphorylated at threonine-181 (P-tau181) and neurofilament light (NfL), may predict future cognitive decline and progression to Alzheimer’s disease dementia in individuals with mild cognitive impairment (MCI), a study shows. In a paper published in Nature Aging, scientists in Sweden showed that the two dementia biomarkers can provide patient-level prognostic ...
Two biomarkers predict Alzheimer’s disease in people with MCI
By Michael Woodhead
2 Dec 2020